Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: A prospective non-randomized controlled trial
Titel:
Ascorbic acid PEG-2L is superior for early morning colonoscopies in colorectal cancer screening programs: A prospective non-randomized controlled trial
Auteur:
Rodríguez de Miguel, C. Serradesanferm, A. López-Cerón, M. Carballal, S. Pozo, A. Balaguer, F. Cárdenas, A. Fernández-Esparrach, G. Ginés, A. González-Suárez, B. Moreira, L. Ordás, I. Ricart, E. Sendino, O. Vaquero, E.C. Ubré, M. del Manzano, S. Grau, J. Llach, J. Castells, A. Pellisé, M.